WESTBROOK, Maine, April 2, 2008 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX) today announced that it has shipped, delivered and recognized first quarter revenue for initial customer deliveries and installations of its two next-generation point-of-care analyzers: the Catalyst Dx(TM) for chemistry analysis and the SNAPshot Dx(TM) for endocrinology testing. Catalyst Dx combines the convenience of immediate results with the accuracy, flexibility, and menu breadth of a reference laboratory, and SNAPShot Dx provides the ability to quickly and conveniently screen for hypothyroidism, hyperthyroidism, Cushing's syndrome, Addison's disease, liver disease and other conditions at the point of care.
Both Catalyst Dx and SNAPshot Dx offer veterinarians enhancements in ease-of-use, speed-to-result, accuracy and throughput, with the ability to run multiple samples for more than one patient simultaneously. In addition, each instrument captures all results in the electronic medical record and automatically integrates the data into the patient diagnostic report and invoice, improving overall practice productivity and workflow efficiencies.
"I am very pleased that we are delivering these important new products on the schedule we outlined over a year ago," said Jonathan W. Ayers, Chairman and Chief Executive Officer. "We have successfully met the key milestones for this complex project, concurrently completing the development, field test and validation for two major diagnostic instrument systems."
The addition of these two innovative instruments to the IDEXX VetLab(R) Suite of in-house analyzers continues the IDEXX tradition of delivering new technologies to the veterinary market that expand the range of point-of-care testing capabilities available to veterinarians. The IDEXX VetLab Suite is a highly integrated set of veterinary analyzers that provides fast and flexible results on a patient's blood and urine within minutes of the pet visit. Diagnostic capabilities of the Suite include clinical chemistry, electrolytes, hematology with five-part differential and reticulocytes, endocrinology, blood gases, coagulation, urinalysis and infectious diseases. The IDEXX VetLab(R) Station, which serves as an information system for the in-house laboratory, uses the power of SmartLink(TM) technology to integrate results from all the analyzers-including the new Catalyst Dx and SNAPshot Dx-and IDEXX SNAP(R) point-of-care tests into a single comprehensive and easy-to-use patient report and stores this information in its database for easy future reference and historical results-trending capability.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice management systems and pharmaceuticals. IDEXX products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,500 people and offers products to customers in over 100 countries.
Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155
|SOURCE IDEXX Laboratories, Inc.|
Copyright©2008 PR Newswire.
All rights reserved